494 related articles for article (PubMed ID: 15343360)
1. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes.
Wang R; Song L; Han G; Wang J; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
Scand J Immunol; 2007 Nov; 66(5):515-22. PubMed ID: 17883389
[TBL] [Abstract][Full Text] [Related]
3. Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells.
Soukhareva N; Jiang Y; Scott DW
Cell Immunol; 2006 Mar; 240(1):41-6. PubMed ID: 16860296
[TBL] [Abstract][Full Text] [Related]
4. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
5. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
[TBL] [Abstract][Full Text] [Related]
6. [Development of rAAV2-GAD-Ig for IDDM gene therapy].
Wang RX; Wang JA; Song L; Han GC; Shen BF; Wu XB; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):24-8. PubMed ID: 15629077
[TBL] [Abstract][Full Text] [Related]
7. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
8. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
[TBL] [Abstract][Full Text] [Related]
9. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
[TBL] [Abstract][Full Text] [Related]
10. Glutamic acid decarboxylase-specific CD4+ regulatory T cells.
Liu CP
Ann N Y Acad Sci; 2006 Oct; 1079():161-70. PubMed ID: 17130549
[TBL] [Abstract][Full Text] [Related]
11. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
[TBL] [Abstract][Full Text] [Related]
12. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
13. CD8+ regulatory T cells are responsible for GAD-IgG gene-transferred tolerance induction in NOD mice.
Wang R; Han G; Song L; Wang J; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
Immunology; 2009 Jan; 126(1):123-31. PubMed ID: 18624731
[TBL] [Abstract][Full Text] [Related]
14. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
Belghith M; Bluestone JA; Barriot S; Mégret J; Bach JF; Chatenoud L
Nat Med; 2003 Sep; 9(9):1202-8. PubMed ID: 12937416
[TBL] [Abstract][Full Text] [Related]
16. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
Chung Y; Lee SH; Kim DH; Kang CY
J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078
[TBL] [Abstract][Full Text] [Related]
17. The role of STAT3 in antigen-IgG inducing regulatory CD4(+)Foxp3(+)T cells.
Wang R; Han G; Wang J; Song L; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
Cell Immunol; 2007 Apr; 246(2):103-9. PubMed ID: 17697673
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta.
Richer MJ; Straka N; Fang D; Shanina I; Horwitz MS
Diabetes; 2008 May; 57(5):1302-11. PubMed ID: 18268045
[TBL] [Abstract][Full Text] [Related]
19. Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold.
Lei TC; Su Y; Scott DW
Cell Immunol; 2005 May; 235(1):12-20. PubMed ID: 16098495
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.
Harnaha J; Machen J; Wright M; Lakomy R; Styche A; Trucco M; Makaroun S; Giannoukakis N
Diabetes; 2006 Jan; 55(1):158-70. PubMed ID: 16380489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
